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Background: Various pathological conditions such as inflammation or injury can evoke pain hypersensitivity. That
represents the response to innocuous stimuli or exaggerated response to noxious stimuli. The molecular
mechanism based on the pain hypersensitivity is associated with changes in many of ion channels in dorsal-root
ganglion (DRG) neurons. Anoctamin 1 (ANO1/TMEM16A), a Ca2+ activated chloride channel is highly visible in small
DRG neurons and responds to heat. Mice with an abolished function of ANO1 in DRG neurons demonstrated
attenuated pain-like behaviors when exposed to noxious heat, suggesting a role in acute thermal nociception.
In this study, we further examined the function of ANO1 in mediating inflammation- or injury-induced hyperalgesia
or allodynia.
Results: Using Advillin/Ano1fl/fl (Adv/Ano1fl/fl) mice that have a functional ablation of Ano1 mainly in DRG neurons,
we were able to determine its role in mediating thermal hyperalgesia and mechanical allodynia induced by
inflammation or nerve injury. The thermal hyperalgesia and mechanical allodynia induced by carrageenan injection
and spared-nerve injury were significantly reduced in Adv/Ano1fl/fl mice. In addition, flinching or licking behavior
after bradykinin or formalin injection was also significantly reduced in Adv/Ano1fl/fl mice. Since pathological
conditions augment nociceptive behaviors, we expected ANO1′s contribution to the excitability of DRG neurons.
Indeed, the application of inflammatory mediators reduced the threshold for action potential (rheobase) or time for
induction of the first action potential in DRG neurons isolated from control (Ano1fl/fl) mice. These parameters for
neuronal excitability induced by inflammatory mediators were not changed in Adv/Ano1fl/fl mice, suggesting an
active contribution of ANO1 in augmenting the neuronal excitability.
Conclusions: In addition to ANO1's role in mediating acute thermal pain as a heat sensor, ANO1 is also capable of
augmenting the excitability of DRG neurons under inflammatory or neuropathic conditions and thereby aggravates
inflammation- or tissue injury-induced pathological pain.
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Pain is one of many diverse sensations that humans
experience in life. Pain is an unpleasant sensation that
evokes suffering in humans. However, pain is also a
warning sign for avoiding tissue injury from impending
external noxious stimuli or aggravated pathological con-
ditions. Acute pain that is mediated by noxious stimuli
from external environments functions as a warning sys-
tem that notifies the risk of immediate injury [1,2]. In
contrast, inflammation, nerve damage, or cancer causes* Correspondence: utoh@snu.ac.kr
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stated.pain hypersensitivity or exaggerated responses to non-
noxious stimuli injury [1,2]. Pain is initiated with the
detection of noxious stimuli at terminals of DRG neu-
rons innervated in peripheral nervous system. Nocicep-
tor is a subclass of DRG neurons that is especially for
transmitting nociceptive neural signals. Most of nocicep-
tors are small-diameter and unmyelinated c-fibers [3].
Nociceptors express many ion channels that are associ-
ated with pain signal generation. Many transient recep-
tor potential (TRP) channels present in DRG neurons
are involved in transducing noxious stimuli to neural
signals [4,5]. In addition to their role as a primary de-
tector for noxious stimuli, these channels also play a role
in transmitting nociceptive signals to the spinal cord,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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TRPV1, which is activated by diverse stimuli such as
capsaicin, anandamide, lipoxygenase products, noxious
heat or low pH [6-9]. TRPV1 is highly visible in nocicep-
tors of DRG neurons and known to play an important
role in transducing these noxious stimuli to nociceptive
neural signals. Because Trpv1−/− mice failed to detect
capsaicin-evoked pain and showed reduced response to
heat, TRPV1 is now known to be a heat sensor that de-
tects noxious heat [9]. In addition, inflammation- and
nerve injury-induced thermal hyperalgesia were also re-
duced in Trpv1−/− mice, suggesting a role for controlling
transmission of nociceptive signals [9,10]. Similarly,
TRPA1 is activated by pungent chemicals or environ-
mental irritants [11,12]. TRPA1 is expressed in nocicep-
tive neurons that are positive to TRPV1 or CGRP. In
addition, bradykinin (BK), an algogenic substance re-
leased by tissue damage, stimulates TRPA1 [11]. TRPA1
appears to contribute to cold hyperalgesia or allodynia
after inflammation and nerve injury, because TRPA1
knock down evoked the reduction of cold hyperalgesia
[13-15]. Thus, many channels in DRG neurons play a
role in detecting noxious stimuli as primary sensors and
are actively involved in modulating transmission of the
nociceptive signals to the central nervous system.
ANO1 is a Cl- channel activated by intracellular Ca2+
[16-18]. ANO1 as a Ca2+-activated Cl- channel mediates
transepithelial fluid secretion in the epithelia of many
organs [19]. Notably, ANO1 is implicated in salivation
[20], mucin secretion in airway [19], intestinal function
[21], and vascular tone [22]. In addition, Yang et al. re-
ported that ANO1 is expressed in DRG neurons, sug-
gesting a role in somatosensation [16]. A later study on
the expression in DRG neurons revealed that ANO1 is
highly co-localized with TRPV1, suggesting a role in
nociception [23]. Surprisingly, ANO1 is activated by heat
over 44°C [23]. Functional ablation of ANO1 in DRG
neurons elicited significant loss of thermal pain [23]. Al-
though these results suggest that ANO1 plays a role in
transducing noxious heat as a heat sensor, it is not
known whether ANO1 is implicated in controlling excit-
ability of sensory neurons, which mediates hyperalgesia
or allodynia evoked by chronic tissue injury. Thus, we
sought to determine ANO1′s roles in regulating hyper-
algesia or allodynia evoked by pathological conditions
such as inflammation or nerve injury.
Methods
Animals
This study was performed in accordance with protocols
approved by the Committee on Laboratory Animals at
Seoul National University. Experiments were also conducted
according to the Ethical Guidelines of the International
Association for the Study of Pain. We crossed Advcre/WTAno1fl/fl homozygote with AdvWT/WT Ano1fl/fl homozy-
gote, producing Advcre/WTAno1fl/fl and AdvWT/WTAno1fl/fl
offsprings. Advcre/WTAno1fl/fl mice were used as conditional
knock-out mice (Adv/Ano1fl/fl) whereas AdvWT/WTAno1fl/fl
homozygote were used as a ‘control’ mice (Ano1fl/fl). Adult
(18 – 23 g) Adv/Ano1fl/fl, and Ano1
fl/fl mice were used for the
behavioral tests. All experiments were performed during the
day time between the hours (9:00 a.m. and 6:00 p.m.).
Animals for all experiments were habituated before testing.
Spared-nerve injury (SNI)-induced neuropathic pain
Neuropathic pain was induced in mice with nerve injury
as described [24]. Briefly, mice were anesthetized by intra-
peritoneal (i.p.) injection of 50 mg/kg pentobarbital. We
checked reflexes by pinching paws using a pincette to test
whether mice were under anesthetic condition. An
incision (~0.3 cm long) around the knee was made in the
longitudinal direction. Nerve injury was induced through
cutting tibial and common peroneal-nerve branches among
three branches of the sciatic nerve.
Hargreaves plantar test
This test was performed using a standard apparatus
(Ugo Basile Biological research Apparatus) as previously
described [25]. Briefly, a mouse was placed in a transpar-
ent acrylic box. An infrared heat lamp was positioned
underneath the targeted hind paw. A radiant stimulus
(intensity 50) was then applied to the plantar surface.
Each test was repeated three times with 5 min interval.
The paw withdrawal latency was calculated as the aver-
age of three values measured.
Von Frey hair test
Mechanical allodynia was measured by prodding the
plantar region of the hindpaw with calibrated von Frey
filaments (Stoelting Co., Wood Dale, IL). Animals were
placed in cages with a mesh grid floor. On testing day,
mice were allowed to acclimate for a minimum of 30 min
before the experiment. Plantar surface of the hind foot
was poked with Von Frey filaments of different thickness.
Withdrawal thresholds to Von Frey filaments were deter-
mined when animals lifted their hindpaw at least 5 re-
sponses out of 10 stimulations. Minimum weight of the
Von Frey filament that evoked a response was considered
as a mechanical withdrawal threshold.
Bradykinin and formalin induced nocifensive behavior
test
Mice were placed in a transparent acrylic box and
allowed to acclimate for approximately 1 hr before injec-
tion. Nocifensive behaviors of mice were measured for
30 min after bradykinin injection. Formalin-induced be-
haviors were evaluated for 45 min being subdivided into
two phases (phase I; 0-15 min, phase II; 15–45 min).
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Drug treatment
To induce inflammation by carrageenan, carrageenan
(2%) was injected subcutaneously into the plantar sur-
face of left hind paws of mice (50 μl). Bradykinin (1 μg)
and formalin (5%, 50 μl) were administered subcutane-
ously into plantar surfaces of left hind paws of control
and Adv/Ano1fl/fl mice. The inflammatory soup con-
tained 10 μM of bradykinin, prostaglandin E2, serotonin,
histamine, respectively. The inflammatory soup was ap-
plied to DRG neurons 2 hr before current clamp record-
ings. All chemicals were purchased from Sigma-Aldrich
and dissolved in physiological saline.
Culture of primary DRG neuron
Primary cell cultures of DRG neurons were conducted
as previously described [23]. Thoracic and lumbar DRGs
were dissected from control and Ano1/Advfl/fl mice, and
collected in cold culture medium (4°C) containing a
mixture of DMEM and F-12 solution, 10% fetal bovine
serum (Gibco BRL), 1 mM sodium pyruvate, 50–100 ng/
ml nerve growth factor (Alomon, Jerusalem, Israel), and
100 units/ml of penicillin/streptomycin. Ganglia was
washed with culture medium and incubated for 30
min in a warm (37°C) DMEM/F-12 mixture containing
1 mg/ml of collagenase (Type II; Worthington Biomedical).
DRGs were then washed 3 times with Mg2+- and Ca2+-free
Hank’s solution, and incubated while gently shaking in
Hank’s solution containing 2.5 mg/ml of trypsin (Roche
Diagnostics) for 30 min at 37°C. The trypsin-containing so-
lution was then centrifuged at 100 g for 10 min. The pellets
obtained after centrifugation were washed gently 2–3 times
with culture medium and gently triturated with a fire-
polished Pasteur pipette. Cells were plated onto round
glass coverslips (Fisher), which had been previously
treated with poly-L-lysine (0.5 mg/ml), in small Petri
dishes (35 × 12 mm). Cells were then placed in a 37°C
incubator in a 95% air/5% CO2 atmosphere. Cells were
used 2–4 days after plating.
Electrophysiology
Current clamp recordings were performed using an
Axopatch 200B (Molecular devices). Data was amplified,
stored in a personal computer after digitization using
Digidata 1440 (Molecular devices). Bath solution con-
tained 140 mM NaCl, 5 mM KCl, 10 mM HEPES, 2 mM
MgCl2, 2 mM CaCl2, adjusted to pH 7.2. Pipette solution
contained 30 mM KCl, 100 mM K-aspartate, 10 mM
HEPES, 1 mM MgCl2, 1 mM EGTA, and 0.225 mM
CaCl2 adjusted to pH7.2. Whole cells were formed after
breaking the plasma membrane under pipette tips. Re-
sistance of the glass pipette was about 3 MΩ. Junctionalpotentials were cancelled to zero. The recordings were
switched to the current clamp configuration. After a
stable baseline was recorded, resting membrane poten-
tial (RMP) was measured in the DRG neurons of inflam-
matory soup treated group and vehicle treated group.
The rheobase was recorded by an injection of current
from 50 pA to 1 nA with 50 pA interval. Current injec-
tion with 1 nA magnitude was used to measure the la-
tency to evoke first action potential spike.
Statistics
All results are expressed as means ± SEMs and were ana-
lyzed by Student-T test. One way ANOVA was used for
multiple comparison of the means followed by Duncan’s
post-hoc test. Statistical significance was accepted for p
values of < 0.05.
Results
Reduction in inflammatory hyperalgesia and allodynia in
Adv/Ano1fl/fl mice
We first investigated whether tissue specific knocked out
of Ano1 in DRG neurons has an effect on inflammatory
hyperalgesia or allodynia. To disrupt functional ANO1 in
DRG neurons, Ano1fl/fl mice were crossed with advillin-
cre transgenic mice (see Methods). Advillin is a member
of the gelsolin family, actin binding proteins and known to
be present exclusively in DRG neurons [26]. The gener-
ation of Adv/Ano1fl/fl mice was confirmed as described
previously [23]. In DRG neurons from Adv/Ano1fl/fl mice,
Ano1 transcripts were absent whereas Nav1.8 and TRPV1
transcripts were not changed (Figure 1A). To induce in-
flammation in a hind paw, carrageenan (2% w/v, 50 μl;
s.c.) was injected into the plantar surface of a left hind
paw of a mouse. The withdrawal latency from radiant heat
was measured at time points of 30, 60, 90, 120, 150 min,
and 24 hours after carrageenan administration (Har-
greaves test). As shown in Figure 1B, apparent significant
decrease (p < 0.001, one way-ANOVA, Duncan post-hoc
test) in the withdrawal latency was observed in control
mice from 30 min after carrageenan injection. The reduc-
tion in withdrawal latency after administration of carra-
geenan was sustained at all time-points tested up to 24 hr.
A significant decrease (p < 0.05, one way-ANOVA, Duncan
post-hoc test) in the withdrawal latency for radiant heat
was also observed in Adv/Ano1fl/fl mice. However, the re-
duction in withdrawal latency in Adv/Ano1fl/fl mice was sig-
nificantly less than that of control mice at all time points (p
< 0.001 ~ 0.05, n = 7–8) (Figure 1B).
To see if the ablation of Ano1 in DRG neurons also af-
fects mechanical allodynia, the Von Frey-hair test was
conducted after the injection of carrageenan to hind
paws of Adv/Ano1fl/fl mice. A significant drop (p < 0.01,
one way-ANOVA, Duncan post-hoc test) in the with-
drawal threshold for mechanical allodynia was observed
A
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Figure 1 Tissue specific ablation of Ano1 in DRG neurons reduces inflammatory thermal and mechanical hyperalgesia. (A) Detection of
ANO1, Nav1.8 and TRPV1 mRNAs in mouse DRG neurons of Ano1fl/fl (control; CTL) and Adv/Ano1fl/fl (conditional knockout; CKO) mice using
reverse transcription-PCR. M, DNA molecular weight markers. (B) Time courses of the withdrawal latency to thermal stimuli were examined in
Adv/Ano1fl/fl and its control mice 30, 60, 90 120, 150 min, 24 hr after carrageenan injection (2%, 50 μl). Radiant heat stimulus (IR 50) was applied to
left paws of Adv/Ano1fl/fl and its control mice (n = 7–8, *p < 0.05, **p < 0.01, ***p < 0.001). Basal withdrawal latency was measured before the injec-
tion of carrageenan. (C) Time courses of withdrawal thresholds of Adv/Ano1fl/fl and its control mice to Von Frey hair stimuli 30, 60, 90 120,
150 min, 24 hr after carrageenan injection. Mechanical stimuli were applied to left hind paws of Adv/Ano1fl/fl and its control mice with Von Frey
hairs (n = 6, **p < 0.01, ***p < 0.001). Basal withdrawal threshold was measured before the injection of carrageenan.
Lee et al. Molecular Pain 2014, 10:5 Page 4 of 9
http://www.molecularpain.com/content/10/1/5in control mice from 30 min after carrageenan injection
(Figure 1C). In contrast, this drop in the withdrawal
threshold for mechanical allodynia after carrageenan in-
jection was not observed in Adv/Ano1fl/fl mice (p < 0.01 ~
0.001, n = 6). Thus, Adv/Ano1fl/fl mice exhibited signifi-
cantly less thermal hyperalgesia and mechanical allody-
nia induced by inflammation.
ANO1 reduces nociception evoked by bradykinin and
formalin
BK has been known as a potent algogenic substance that
is released when tissue is injured [27,28]. In addition, BK
is known to induce nocifensive behaviors via activation
of CaCCs because BK-induced nocifensive behaviors
were reduced by CaCC blockers in rats [29]. Therefore,
we attempted to confirm whether ANO1 mediates BK-
evoked nociception. The subcutaneous injection of 1 μg
BK into the plantar surface of hind paws of the control
mice induced nocifensive behaviors for 52 ± 11 seconds
(n = 8) (Figure 2A). However, these nocifensive behaviors
after BK injection lasted only 20.7 ± 4.9 seconds (n = 8)
in Adv/Ano1fl/fl mice, significantly (p < 0.05) shorter than
those for control mice (Figure 2A).
Formalin is also a well-known algogenic chemical that
produces nocifensive responses. Formalin-induced noci-
fensive behaviors are subdivided into two phases [30,31].The first phase of nocifensive behaviors that lasts for
10 min after the formalin injection is caused by direct
stimulation of sensory nerves whereas the second phase
starting 10 min after formalin injection is mediated by
inflammatory reaction [30,31]. As shown in Figure 2B,
ablation of Ano1 in DRG neurons is resulted in a signifi-
cant decrease in the duration of nocifensive behaviors in
the 2nd phase of nociception after formalin injection
(230 ± 46 vs 123 ± 15.9 s, p < 0.05, n = 6–7). In contrast,
Adv/Ano1fl/fl mice failed to show the difference in the
duration of nocifensive behaviors in the first phase
(0–10 min) after formalin injection when compared to
that of control mice. Thus, these results further indicate
that ANO1 is involved in mediating BK- or formalin-
induced inflammatory pain.
Reduction in neuropathic hyperalgesia and allodynia in
Adv/Ano1fl/fl mice
We then examined whether ANO1 could contribute to
neuropathic hyperalgesia and allodynia. A spared nerve
injury (SNI) model was adopted to induce neuropathic
pain after cutting 2 out of 3 branches of the sciatic nerve
(see Methods). Hargreaves and Von Frey hair tests were
performed in hind paws of control and Adv/Ano1fl/fl
mice on every week for a 4-week period after nerve in-
jury. Starting from one-week after surgery, withdrawal
Figure 2 Ablation of ANO1 in DRG neurons attenuates bradykinin and formalin induced nociception. (A) Nocifensive behaviors were
counted for 30 min after bradykinin (1 μg, 50 μl) was injected to left hind paws of Adv/Ano1fl/fl and its control mice (*p < 0.05, n = 8). (B)
Nocifensive behaviors were counted for 45 min after formalin (5%, 50 μl) was injected to left hind paws of Adv/Ano1fl/fl and its control mice (*p <
0.05, n = 6–7). Phase I represents measurement for the first 15 min while phase II represents measurement for 15 ~ 45 min.
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ipsilateral paws of control mice (p < 0.001, one way-
ANOVA, Duncan post-hoc test, n = 5) (Figure 3A). The
withdrawal latency of ipsilateral paws of Adv/Ano1fl/fl
mice was also significantly reduced after the nerve injury
(p < 0.001, one way-ANOVA, Duncan post-hoc test, n = 6)
(Figure 3A). However, the reduction in the withdrawal
latency was significantly smaller than that of control mice
for all time points of measurement (p < 0.01 ~ 0.05, n = 5
– 6) (Figure 3A).
Through the significant reduction (p < 0.01, one way-
ANOVA, Duncan post-hoc test, n = 6) in the withdrawal
threshold to Von Frey hairs after the nerve injury, mech-
anical allodynia was evident in ipsilateral hind paws of
control mice after the nerve injury (Figure 3B). The re-
duction in the withdrawal threshold was not observed in
contralateral hind paws of control mice. Significant
mechanical allodynia (p < 0.01, one way-ANOVA, Duncan
post-hoc test, n = 6) was also evident in ipsilateral hind
paws of Adv/Ano1fl/fl mice. However, the reduction in theA
Figure 3 Ablation of ANO1 in DRG neurons reduces spinal nerve inju
pain was induced on a hind paw after dissecting two out of three branche
contralateral (contra) hind paws of Adv/Ano1fl/fl and control mice were mea
***p < 0.001 compared to the withdrawal latency of ipsilateral hind paw of
before the surgery. (B) Withdrawal thresholds of ipsilateral and contralatera
Frey hairs after spared nerve injury (*p < 0.05, **p < 0.01 compared to the wwithdrawal threshold after nerve injury was significantly
smaller than that of control mice (p < 0.01 ~ 0.05, n = 5–6,
Figure 3B). These results indicate that ANO1 plays a role in
thermal hyperalgesia and mechanical allodynia induced by
nerve injury.
ANO1 augments the excitability of DRG neurons
We then investigated whether ANO1 might contribute to
the change in the excitability of DRG neurons under in-
flammatory condition. In order to determine changes in
excitability, currents from 50 pA to 1 nA were injected to
DRG neurons to measure the rheobase as a parameter for
excitability, a minimal current that evokes an action po-
tential [32,33]. In addition, latency to induce the first ac-
tion potential was also measured when a current of 1 nA
was injected to a DRG neuron as another parameter
for excitability [34]. To imitate inflammatory condition, an
inflammatory soup (IS), a mixture of four inflammatory
mediators such as BK, prostaglandin E2, histamine, and
serotonin was applied to primary-cultured DRG neuronsB
ry-induced thermal and mechanical hyperalgesia. (A) Neuropathic
s in the sciatic nerve. Paw withdrawal latencies of ipsilateral (Ipsi) and
sured in response to radiant heat after spared nerve injury (*p < 0.05,
control mice, n = 5–6). Basal paw withdrawal latency was measured
l hind paws of Adv/Ano1fl/fl and control mice were measured with Von
ithdrawal threshold of ipsilateral hind paw of control mice, n = 5–6).
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110 mM K-aspartate and 50 nM free Ca2+ whereas the
bath solution contained 140 mM NaCl and 5 mM KCl.
When the vehicle was applied to DRG neurons isolated
from control mice, the rheobase was 500.0 ± 32.3 pA
(n = 22) (Figure 4B). However, when DRG neurons were
incubated with the IS for 2 hr, the rheobase was signifi-
cantly decreased to 357.5 ± 18.3 pA (p < 0.001, n = 20),
suggesting an increased excitability after the IS treat-
ment. When DRG neurons from Adv/Ano1fl/fl mice
were incubated with IS, the rheobase was also signifi-
cantly reduced (530.0 ± 23.9 (n = 25) vs 444.7 ± 20.7 pA
(n = 19), p < 0.05). However, the reduction in the rheo-
base in the IS- treated DRG neurons from Adv/Ano1fl/fl
mice was significantly less than that of control mice
(*p < 0.05, one-way ANOVA, Duncan’s post-hoc test)
(Figure 4B). Similarly, the IS application to DRG neurons
of control mice reduced a latency to induce the first action
potential after 1 nA current injection significantly (p <
0.05) when compared to that of vehicle-treated DRGA
C
Figure 4 Ablation of ANO1 in DRG neurons reduces inflammation-ind
potentials evoked by current injections to DRG neurons of control mice. Rheo
potential (red). Depolarizing currents with 5 ms duration were injected to wh
pA increment (inset). Bath solution contained 140 mM NaCl whereas pipette
Rheobases of DRG neurons isolated from Adv/Ano1fl/fl and control mice were
Note that the rheobase was lowered in IS-treated DRG neurons both from co
treated DRG neurons from Adv/Ano1fl/fl mice was significantly less than that o
< 0.001, *p < 0.05 compared to the rheobase of the vehicle-treated DRG neur
Latencies to first action potential (AP) were measured in DRG neurons of Adv/
inflammatory soup (IS). Current with 1 nA magnitude was injected to evoke t
ened in IS-treated DRG neurons from control mice whereas the latency to the
Ano1fl/fl mice. *p < 0.05 compared to the latency of vehicle-treated DRG neuro
membrane potentials of DRG neurons from Adv/Ano1fl/fl and control mice we
each group is same as shown in B. *p < 0.05.neurons (Figure 4C). In contrast, the IS application failed
to change the latency for the induction of the first action
potential in DRG neurons from Adv/Ano1fl/fl mice
(Figure 4C). The resting membrane potential of DRG neu-
rons isolated from control mice depolarized significantly
from −59.6 ± 0.9 mV to −56.7 ± 0.9 mV (p < 0.05) after the
IS treatment, suggesting the increased excitability in
the resting state (Figure 4D). In contrast, the resting
membrane potential of DRG neurons isolated
from Adv/Ano1fl/fl mice was not affected by the IS
treatment (Figure 4D). These results indicate that
ANO1 augments excitability of DRG neurons during
inflammation.
Discussion
ANO1 is activated by intracellular Ca2+ and mediates
many physiological functions as a candidate gene for
Ca2+-activated Cl- channel [16-18,20,21,36]. Mostly,
ANO1 is present in nociceptors of DRG neurons [16,23].




uced excitability of DRG neurons. (A) Example traces of action
base was determined as a current required for activating the first action
ole cells of DRG neurons from control mice from 50 pA to 1 nA with 50
solution contained 30 mM Cl- and 50 nM free Ca2+ (see Methods). (B)
measured in the absence (vehicle) or presence of inflammatory soup (IS).
ntrol and Adv/Ano1fl/fl mice. But, the reduction in the rheobase in IS-
f control mice (*p < 0.05, one-way ANOVA, Duncan’s post-hoc test). ***p
ons. Numbers in parenthesis represent the number of neurons tested. (C)
Ano1fl/fl and control mice under the condition of absence or presence of
he action potential spike. Note that the latency to the first AP was short-
first AP was not changed with IS treatment in DRG neurons from Adv/
ns. Number of neurons in each group is same as shown in B. (D) Resting
re measured under the inflammatory condition. Number of neurons in
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displayed reduced nociceptive behaviors in response to
heat [23]. The present study extends its role from a heat
transducer to a regulator of transmission of nociceptive
signals evoked by inflammation or neuropathy. Indeed,
ANO1 plays an active role in mediating inflammatory as
well as neuropathic pain because inflammation or nerve-
injury induced hyperalgesia or allodynia was reduced in
Adv/Ano1fl/fl mice. The decreased excitability in Adv/
Ano1fl/fl mice may account for the apparent reduced
hyperalgesia and allodynia during inflammation. Thus, in
addition to its ability of transducing acute noxious thermal
stimuli to nociceptive neural signals, ANO1 is susceptible
to intracellular signals that shape or affect transmission of
nociceptive signals to the spinal cord during pathological
conditions.
Thermal or mechanical hyperalgesia and allodynia are
common features of neuropathic pain or inflammatory
pain [1,5]. Pathological pain occurs in response to vari-
ous inflammatory mediators such as prostaglandins, his-
tamine, BK, ATP, serotonin (5-HT), proton, cytokines,
growth factors, and neuropeptides that are released from
inflammed or injured tissues [37]. These chemicals
evoke peripheral sensitization, resulting in enhancement
of the excitability of nociceptive nerve fibers. Several
intracellular signaling pathways are known to cause the
peripheral sensitization [38]. Some inflammatory agents
such as BK, prostaglandins, ATP or endothelin-1 activate
various protein kinases and modulate channels via phos-
phorylation [39-42]. The target channels would be
TRPV1, TRPA1, and Nav1.8 that are expressed in termi-
nals of nociceptors [43,44]. Similarly, ANO1 is highly
expressed in nociceptors and activated by heat and also
has multiple protein kinase consensus sites for protein
kinase A, casein kinase, and other protein kinases
[16,23]. Because ANO1 regulates the inflammation-
induced membrane excitability in DRG neurons (Figure 4),
phosphorylation of ANO1 by several kinases may account
for the change of excitability of sensory neurons caused by
inflammation.
Many thermoTRP channels are activated by multiple
stimuli such as their respective ligands, voltage, and
changes in temperature, which often produce synergistic
effect among each other on their activities [7,45]. Re-
sponses of TRPV1 by heat and capsaicin were markedly
potentiated by moderate acid that normally does not in-
duce any TRPV1 current. In addition, TRPM3 has a
strong synergistic effect between heat and pregnenolone
sulfate, a neuroactive steroid [45]. The temperature-
response curve of TRPM3 was shifted leftward by preg-
nenolone sulfate. Similarly, activity of ANO1 by heat is
markedly augmented by its endogenous ligand, Ca2+.
The increase in intracellular Ca2+ enhances heat-evoked
ANO1 currents, decreasing the temperature threshold ofANO1 below 44°C [23]. For instance, when intracellular
Ca2+ was increased above 0.5 μM, ANO1 was activated
by the temperature close to body temperature, 37.5°C.
Because inflamed tissues can cause the increase in intra-
cellular Ca2+ [2,46], it is conceivable that ANO1 can be
sensitized by heat at body temperature under such a
pathological condition.
It has been suggested that the regulation of intracellu-
lar Cl- concentration in sensory neurons is involved in
the mediation of inflammatory hyperalgesia or transmis-
sion of nociceptive signals [47,48]. Numerous studies
have explained that the accumulation of intracellular Cl-
by NKCC1 which cause Cl- uptake is correlated with
pain behaviors. Nociceptive behaviors induced by forma-
lin injection were significantly attenuated by NKCC1
blockers, bumetanide and furosemide [49]. In addition,
itch and flare responses by histamine injection were also
reduced by these NKCC1 blockers [50,51]. If intracellu-
lar Cl- concentration is increased in inflamed tissues, the
driving force of Cl- to depolarization becomes greater
when ANO1 is activated. Thus, an increase in intracellular
Cl- concentration during inflammation would also con-
tribute to the ANO1′s role in mediating chronic pain.
In summary, the present study revealed that Ano1 de-
letion in DRG neurons reduced inflammation and
neuropathy-induced hyperalgesia and allodynia. In
addition, the sensitization of DRG neurons induced by
inflammation mediators was also absent in Ano1-
ablated DRG neurons. These results suggest that ANO1
contributes to the sensitization of nociceptors during
pathological conditions. The involvement of ANO1 in
regulating the inflammatory or nerve-injury evoked
pain may lead to the possibility that antagonists of
ANO1 can be developed as novel analgesics.Competing interests
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